Quality of life in pediatric oncology patients, caregivers and siblings after psychosocial screening: a randomized controlled trial
Quality of life in pediatric oncology patients, caregivers and siblings after psychosocial screening: a randomized controlled trial
复制标题
DOI：
10.1007/s00520-019-05160-x
复制
发表时间：
2020-08-01
影响因子：
3.1
通讯作者：
Mills, Denise
中科院分区：
文献类型：
--
作者：
Barrera, Maru;Hancock, Kelly;Mills, Denise
目的 我们评估了使用经过验证的措施（心理社会评估工具，PAT）进行心理社会筛查并向患者治疗团队提供 PAT 结果摘要是否可以改善新诊断癌症患者、其护理人员和兄弟姐妹的生活质量 (QOL)，以及与初始家庭心理社会风险的关系。方法 在两个加拿大儿科癌症中心，家庭被随机分配到干预组（IG，治疗组收到描述低、中或高社会心理风险的 PAT 总结）或对照组（CG，没有向治疗组提供总结）。新诊断癌症儿童的护理人员 (N = 122)、患者 (n = 36) 和兄弟姐妹 (n = 25) 在诊断后 2-4 周 (T1) 和 6 个月 (T2) 完成了 QOL 评估。护理人员还为患者和兄弟姐妹完成了 PAT 和代理 QOL。结果 一般来说，随着时间的推移，与 CG 相比，IG 中的患者代理总 QOL 有所改善，但仅适用于高社会心理风险患者 (p< .05)。无论分组如何，患者代理癌症相关的生活质量都会随着时间的推移而改善；随着时间的推移，护理人员的生活质量也有所改善 (ps < .05)。结论 本研究证明，心理社会筛查结果仅对诊断前心理社会风险较高的代理患者生活质量结果有好处。评估儿科肿瘤患者的生活质量益处对于确定社会心理筛查的临床价值至关重要。
Objective We evaluated whether conducting psychosocial screening using a validated measure (the Psychosocial Assessment Tool, PAT) and providing a summary of PAT results to the patient's treating team improves quality of life (QOL) in newly diagnosed patients with cancer, their caregivers and siblings, in general, and in relation to the initial family psychosocial risk. Methods Families were randomly allocated to an intervention (IG, treating team received PAT summary describing low, medium, or high psychosocial risk) or control group (CG, no summary provided to treating team) in two Canadian pediatric cancer centers. Caregivers (N= 122) of children newly diagnosed with cancer, patients (n= 36), and siblings (n= 25) completed QOL assessments at 2-4 weeks (T1) and 6 months post-diagnosis (T2). Caregivers also completed PAT and proxy QOL for patient and sibling. Results In general, patient-proxy total QOL improved in IG compared to CG over time but only for high psychosocial risk patients (p< .05). Patient proxy cancer-related QOL improved over time regardless of group allocation; caregiver QOL also improved over time (ps < .05). Conclusion This study demonstrated the benefits of psychosocial screening results only on proxy patient QOL outcomes with high psychosocial risk near diagnosis. Evaluating QOL benefits in pediatric oncology patients is critical for establishing the clinical value of psychosocial screening.